Vancouver, BC / March 10, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it is now trading on the Frankfurt Stock Exchange. BioHarvest Sciences Inc. is now listed on the Frankfurt Stock Exchange (also known as the Deutsche Boerse AG) under WKN: A2P3RM and the symbol 8MV. The company’s shares […]
BioHarvest Sciences Inc. Announces Listing on Frankfurt Stock Exchange Read More »
The product will include polyphenols known to have significant health benefits. Vancouver, BC / March 4, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) has reached an important milestone in its development program of additional Nutraceuticals. The olive based Nutraceutical product scheduled for market availability in the second half of 2022 will
Vancouver, BC / February 25, 2021 / BioHarvest Sciences Inc. (the “Company”, “BioHarvest”) (CSE: BHSC) announces that it has granted a total of 6,000,000 stock options to the Company’s Chief Technical Officer, Dr Yochi Hagay. The stock options granted are exercisable to purchase a common share of the Company at a price of $0.66 per
BIOHARVEST SCIENCES INC. ANNOUNCES GRANT OF STOCK OPTIONS Read More »
This project will highlight the sustainability credentials and advantages of BioHarvest’s BioFarming technology. Vancouver, BC / February 16, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC)announces that it has entered into a partnership with BOLDT AG, an international business strategy and communications consultancy based in Europe, and Summit Strategy Group LLC, a
This milestone is critical for the large-scale production of full-spectrum plant-based cannabis products and cannabinoids in liquid media bioreactors. Vancouver, BC / February 9, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it is now able to consistently grow Trichomes from multiple cannabis plant strains, in liquid media. Furthermore, BioHarvest
Vancouver, BC / February 4, 2021 / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) announces that it has signed a financial advisory agreement with Cukierman & Co. Investment House Ltd., a full service Israeli financial advisory firm with life sciences expertise and global capabilities, granting it a mandate to explore opportunities for the
